HORMONE REPLACEMENT THERAPY (HRT) MAY IMPROVE PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FUNCTION

The use of hormone replacement therapy (HRT) may be associated with improved pulmonary hypertension in women, according to research presented at the ATS 2024 International Conference. Pulmonary hypertension (PH) is a type of pulmonary vascular disease—disease that affects blood vessels along the route between the heart and lungs.

Cedars-Sinai Pulmonary and Critical Care Experts Present Latest Research at International Conference

Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.

Complications for procedure to open clogged pulmonary arteries decrease significantly

Complications after a minimally invasive balloon pulmonary angioplasty have decreased substantially over the last decade for patients with high blood pressure in their pulmonary arteries caused by chronic blood clots, known as CTEPH. The procedure, which is offered for patients who are not candidates for surgery, involves inflating a balloon inside of diseased lung arteries to break up clots and restore blood flow to the lungs.

Smidt Heart Institute: Annual Report Highlights

The 2022 Annual Report from the Smidt Heart Institute at Cedars-Sinai is available now, detailing the latest research and medical achievements by the expert team ranked No. 1 for cardiology and cardiac surgery in California by U.S. News & World Report.

Lack of DUSP5 Protein Leads to Pulmonary Hypertension and Heart Enlargement in Mice

Article title: DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy Authors: Bradley S. Ferguson, Sara A. Wennersten, Kimberly M. Demos-Davies, Marcello Rubino, Emma L. Robinson, Maria A. Cavasin, Matthew S. Stratton, Andrew M. Kidger, Tianjing…

Dr. Abhishek Singh to Lead Atlantic Health System’s Heart Success Program

Atlantic Health System has announced that Abhishek Singh, MD, PhD, has been named Medical Director of Atlantic Health System’s Heart Success program, which cares for patients with advanced heart failure. Dr. Singh is triple board-certified in internal medicine, cardiology, and advanced heart failure and transplant cardiology.

Research News Tip Sheet: Story Ideas From Johns Hopkins

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday, throughout the duration of the outbreak.

Enzyme + Mitochondrial Signaling May Contribute to Pulmonary Hypertension in Newborns

Article title: PKCβ and reactive oxygen species mediate enhanced pulmonary vasoconstrictor reactivity following chronic hypoxia in neonatal rats Authors: Joshua R. Sheak, Simin Yan, Laura Weise-Cross, Rosstin Ahmadian, Benjimen R. Walker, Nikki L. Jernigan From the authors: “This research demonstrates a novel…